Corentec Co

Corentec Co Accounts Payable

The Accounts Payable of Corentec Co (104540.KQ) as of Nov 6, 2026 is 14.27 B KRW. In the previous year, Accounts Payable was 12.61 B KRW — a change of 13.23% (higher).

Accounts Payable

14.27 BKRW

YoY

13.23%

Last updated:

Accounts Payable of Corentec Co is 2025 14.27 B KRW. Accounts Payable of Corentec Co was 2024 12.61 B KRW. It decreases by 13.23% higher compared to the previous year.

The Corentec Co Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
1.80 B KRW
Jan 1, 2019
1.87 B KRW
Jan 1, 2020
1.95 B KRW
Jan 1, 2021
1.59 B KRW
Jan 1, 2022
8.77 B KRW
Jan 1, 2023
14.69 B KRW
Jan 1, 2024
12.61 B KRW
Jan 1, 2025
14.27 B KRW
The Corentec Co Accounts Payable history
YEARAccounts PayableYoY
14.27 BKRW+13.23%
12.61 BKRW-14.16%
14.69 BKRW+67.42%
8.77 BKRW+453.32%
1.59 BKRW-18.90%
1.95 BKRW+4.73%
1.87 BKRW+3.58%
1.80 BKRW+53.18%
1.18 BKRW-21.03%
1.49 BKRW+104.51%
728.42 MKRW-52.90%
1.55 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Accounts Payable of Corentec Co is 14.27 B KRW in 2025.

Accounts Payable of Corentec Co changed from 12.61 B KRW to 14.27 B KRW, representing a 13.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Corentec Co

All Key Metrics — Corentec Co